{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:54:13Z","timestamp":1791258853914,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,6]],"date-time":"2027-10-06T00:00:00Z","timestamp":1822780800000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jval.2026.02.002","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:56:41Z","timestamp":1771865801000},"page":"1791-1799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Caregiver Meaningful Score Differences and Meaningful Score Regions for the Observer-Reported Communication Ability Measure for Individuals with Angelman Syndrome"],"prefix":"10.1016","volume":"29","author":[{"given":"Abigail","family":"Rader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Sadhwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson","family":"Berent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batsheva","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hann","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce B.","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Namestnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetha","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jval.2026.02.002_bib1","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41431-019-0446-x","article-title":"A retrospective analysis of the prevalence of imprinting disorders in Estonia from 1998 to 2016","volume":"27","author":"Yakoreva","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jval.2026.02.002_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/TACG.S57386","article-title":"Angelman syndrome: review of clinical and molecular aspects","volume":"7","author":"Bird","year":"2014","journal-title":"Appl Clin Genet"},{"issue":"2","key":"10.1016\/j.jval.2026.02.002_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jmg.40.2.87","article-title":"Angelman syndrome: a review of the clinical and genetic aspects","volume":"40","author":"Clayton-Smith","year":"2003","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.jval.2026.02.002_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1891\/0730-0832.36.3.142","article-title":"Angelman syndrome: identification and management","volume":"36","author":"Bonello","year":"2017","journal-title":"Neonatal Netw"},{"issue":"3","key":"10.1016\/j.jval.2026.02.002_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s13311-015-0361-y","article-title":"Angelman syndrome","volume":"12","author":"Margolis","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.jval.2026.02.002_bib6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrneurol.2016.133","article-title":"Angelman syndrome\u2014insights into a rare neurogenetic disorder","volume":"12","author":"Buiting","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.jval.2026.02.002_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/DBP.0b013e3181ee408e","article-title":"A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations","volume":"31","author":"Gentile","year":"2010","journal-title":"J Dev Behav Pediatr"},{"issue":"12","key":"10.1016\/j.jval.2026.02.002_bib9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/humu.22687","article-title":"Mutation Update for UBE3A variants in Angelman syndrome","volume":"35","author":"Sadikovic","year":"2014","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.jval.2026.02.002_bib10","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ymthe.2023.01.013","article-title":"Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model","volume":"31","author":"O\u2019Geen","year":"2023","journal-title":"Mol Ther"},{"issue":"12","key":"10.1016\/j.jval.2026.02.002_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027221","article-title":"Adeno-associated virus-mediated rescue of the cognitive defects in a mouse model for Angelman syndrome","volume":"6","author":"Daily","year":"2011","journal-title":"PLOS One"},{"issue":"12","key":"10.1016\/j.jval.2026.02.002_bib12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/hmg\/ddab104","article-title":"Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells","volume":"30","author":"Adhikari","year":"2021","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.jval.2026.02.002_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142574","article-title":"CRISPR\/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice","volume":"131","author":"Schmid","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jval.2026.02.002_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41421-024-00727-3","article-title":"Epigenetic editing alleviates Angelman syndrome phenotype in mice by unsilencing paternal Ube3a","volume":"10","author":"Liu","year":"2024","journal-title":"Cell Discov"},{"issue":"4","key":"10.1016\/j.jval.2026.02.002_bib15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s10578-020-01051-z","article-title":"Measuring what matters to individuals with Angelman syndrome and their families: development of a patient-centered disease concept model","volume":"52","author":"Willgoss","year":"2021","journal-title":"Child Psychiatry Hum Dev"},{"issue":"1","key":"10.1016\/j.jval.2026.02.002_bib17","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1111\/jar.12305","article-title":"Quantitative measurement of communication ability in children with Angelman syndrome","volume":"31","author":"Grieco","year":"2018","journal-title":"J Appl Res Intellect Disabil"},{"issue":"11","key":"10.1016\/j.jval.2026.02.002_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/dmcn.14257","article-title":"Communication in Angelman syndrome: a scoping review","volume":"61","author":"Pearson","year":"2019","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"10.1016\/j.jval.2026.02.002_bib20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1352\/1944-7558-128.3.204","article-title":"Validation of the Observer-Reported Communication Ability (ORCA) measure for individuals with Angelman syndrome","volume":"128","author":"Zigler","year":"2023","journal-title":"Am J Intellect Dev Disabil"},{"issue":"1","key":"10.1016\/j.jval.2026.02.002_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Human Services FDA Center for Biologics, Human Services FDA Center for Devices, and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","year":"2006","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"10.1016\/j.jval.2026.02.002_bib23","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s11136-012-0344-y","article-title":"ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research","volume":"22","author":"Reeve","year":"2013","journal-title":"Qual Life Res"},{"issue":"8","key":"10.1016\/j.jval.2026.02.002_bib24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1524-4733.2009.00603.x","article-title":"Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report","volume":"12","author":"Rothman","year":"2009","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2026.02.002_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/ebmental-2020-300164","article-title":"Mind the methods of determining minimal important differences: three critical issues to consider","volume":"24","author":"Devji","year":"2021","journal-title":"Evid Based Ment Health"},{"issue":"1","key":"10.1016\/j.jval.2026.02.002_bib26","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207958","article-title":"FDA patient-focused drug development guidances: considerations for trial readiness in rare developmental and epileptic encephalopathies","volume":"102","author":"Berg","year":"2024","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jval.2026.02.002_bib27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s12325-019-00920-x","article-title":"The case for the use of patient and caregiver perception of change assessments in rare disease clinical trials: a methodologic overview","volume":"36","author":"Contesse","year":"2019","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.jval.2026.02.002_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41687-019-0100-y","article-title":"An overview of using qualitative techniques to explore and define estimates of clinically important change on clinical outcome assessments","volume":"3","author":"Staunton","year":"2019","journal-title":"J Patient Rep Outcomes"},{"issue":"11","key":"10.1016\/j.jval.2026.02.002_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002966","article-title":"Noncompletion and nonpublication of trials studying rare diseases: a cross-sectional analysis","volume":"16","author":"Rees","year":"2019","journal-title":"PLOS Med"},{"key":"10.1016\/j.jval.2026.02.002_bib30","author":"Sparrow"},{"key":"10.1016\/j.jval.2026.02.002_bib31","series-title":"Bayley Scales of Infant and Toddler Development","author":"Bayley","year":"2019"},{"key":"10.1016\/j.jval.2026.02.002_bib32","doi-asserted-by":"crossref","unstructured":"Pepperdine CR, McCrimmon AW. Test review: Vineland Adaptive Behavior Scales. 3rd ed. (Vineland-3) by Sparrow, SS, Cicchetti, DV, & Saulnier, CA. Can J Sch Psychol. 2018;33(2):157-163.","DOI":"10.1177\/0829573517733845"},{"issue":"10","key":"10.1016\/j.jval.2026.02.002_bib33","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1007\/s10803-023-06090-8","article-title":"Adaptive skills of individuals with Angelman syndrome assessed using the Vineland Adaptive Behavior Scales. 2nd ed","volume":"54","author":"Gwaltney","year":"2023","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"10.1016\/j.jval.2026.02.002_bib34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13023-025-03817-x","article-title":"Using the Bayley-4 and Vineland-3 in Angelman syndrome: barriers, solutions, and challenging items","volume":"20","author":"Halpin","year":"2025","journal-title":"Orphanet J Rare Dis"},{"issue":"1-2","key":"10.1016\/j.jval.2026.02.002_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ymgme.2022.09.001","article-title":"Increasing precision in the measurement of change in pediatric neurodegenerative disease","volume":"137","author":"Eisengart","year":"2022","journal-title":"Mol Genet Metab"},{"issue":"11","key":"10.1016\/j.jval.2026.02.002_bib37","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1007\/s11136-017-1625-2","article-title":"Idio Scale Judgment: evaluation of a new method for estimating responder thresholds","volume":"26","author":"Cook","year":"2017","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jval.2026.02.002_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s11689-022-09474-6","article-title":"Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study","volume":"15","author":"Farmer","year":"2023","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.jval.2026.02.002_bib39","author":"Sadhwani"},{"key":"10.1016\/j.jval.2026.02.002_bib40","article-title":"Bayley Scales of infant and toddler development","author":"Balasundaram","year":"2024","journal-title":"StatPearls"},{"key":"10.1016\/j.jval.2026.02.002_bib41","series-title":"Encyclopedia of Child Behavior and Development","first-page":"215","article-title":"Bayley scales of infant development. 3rd ed","author":"Michalec","year":"2011"},{"issue":"6","key":"10.1016\/j.jval.2026.02.002_bib42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/17405629.2018.1485563","article-title":"A longitudinal study of the predictive validity of the Bayley-III scales and subtests","volume":"16","author":"Krogh","year":"2019","journal-title":"Eur J Dev Psychol"},{"issue":"9","key":"10.1016\/j.jval.2026.02.002_bib43","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/DBP.0000000000000110","article-title":"Predictive validity of the Bayley, Third edition at 2 years for intelligence quotient at 4 years in preterm infants","volume":"35","author":"Bode","year":"2014","journal-title":"J Dev Behav Pediatr"},{"issue":"2","key":"10.1016\/j.jval.2026.02.002_bib44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1542\/peds.2005-0173","article-title":"Poor predictive validity of the Bayley Scales of Infant Development for cognitive function of extremely low birth weight children at school age","volume":"116","author":"Hack","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jval.2026.02.002_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.earlhumdev.2018.07.002","article-title":"Validity and cross-cultural differences of the Bayley Scales of Infant and Toddler Development, Third Edition in typically developing infants","volume":"125","author":"Hoskens","year":"2018","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.jval.2026.02.002_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.earlhumdev.2019.01.017","article-title":"The reliability and validity of Bayley-III cognitive scale in China\u2019s male and female children","volume":"129","author":"Hua","year":"2019","journal-title":"Early Hum Dev"},{"issue":"3","key":"10.1016\/j.jval.2026.02.002_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.PEP.0000136005.41585.FE","article-title":"Concurrent validity of the Bayley Scales of Infant Development II motor scale and the Peabody developmental motor Scales-2 in children with developmental delays","volume":"16","author":"Provost","year":"2004","journal-title":"Pediatr Phys Ther"},{"issue":"2","key":"10.1016\/j.jval.2026.02.002_bib48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajmg.a.30065","article-title":"Cognitive and adaptive behavior profiles of children with Angelman syndrome","volume":"128A","author":"Peters","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.jval.2026.02.002_bib49","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s10803-020-04861-1","article-title":"Developmental skills of individuals with Angelman syndrome assessed using the Bayley-III","volume":"53","author":"Sadhwani","year":"2023","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"10.1016\/j.jval.2026.02.002_bib50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s11689-023-09494-w","article-title":"Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)","volume":"15","author":"Tjeertes","year":"2023","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.jval.2026.02.002_bib51","series-title":"Bayley Scales of Infant and Toddler Development","author":"Bayley","year":"2006"},{"key":"10.1016\/j.jval.2026.02.002_bib52","series-title":"International Review of Research in Developmental Disabilities","first-page":"1","article-title":"Chapter One. Psychometric perspectives on developmental outcome and endpoint selection in treatment trials for genetic conditions associated with neurodevelopmental disorder","author":"Farmer","year":"2022"},{"issue":"10","key":"10.1016\/j.jval.2026.02.002_bib8","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jval.2025.11.021","article-title":"Developing meaningful score differences for the Bayley-4 and Vineland-3 in Angelman Syndrome using a Delphi panel","volume":"29","author":"Powers","year":"2026","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2026.02.002_bib54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jval.2026.02.002_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"10.1016\/j.jval.2026.02.002_bib56","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"2013"},{"issue":"5","key":"10.1016\/j.jval.2026.02.002_bib57","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jclinepi.2014.07.008","article-title":"Minimally important change values of a measurement instrument depend more on baseline values than on the type of intervention","volume":"68","author":"de Vet","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.jval.2026.02.002_bib58","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/aur.1874","article-title":"Adaptive behavior in autism: minimal clinically important differences on the Vineland-II","volume":"11","author":"Chatham","year":"2018","journal-title":"Autism Res"},{"issue":"1","key":"10.1016\/j.jval.2026.02.002_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11136-015-1058-8","article-title":"Estimating minimally important difference (MID) in PROMIS pediatric measures using the scale-judgment method","volume":"25","author":"Thissen","year":"2016","journal-title":"Qual Life Res"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301526000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301526000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:45:30Z","timestamp":1791258330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301526000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1098301526000744"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2026.02.002","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caregiver Meaningful Score Differences and Meaningful Score Regions for the Observer-Reported Communication Ability Measure for Individuals with Angelman Syndrome","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2026.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}